Main useUsed for selected rheumatoid arthritis, atopic dermatitis and inflammatory bowel disease, depending on formulation.A brief overview of Japanese approved uses. Check the PMDA label below for product-specific conditions.
- Japan product name
- リンヴォック錠7.5mg／15mg／30mg／45mg・内用液0.1%
- Brand
- Rinvoq
- Generic name
- Upadacitinib
- Japanese generic name
- ウパダシチニブ
- Chinese name
- 乌帕替尼
- Marketing authorization holder
- アッヴィ合同会社
- Strengths
- 7.5 mg / 15 mg / 30 mg / 45 mg; oral solution 0.1%
- Dosage form
- tablet / oral solution
- Therapeutic area
- Immunologie
- Regulatory status
- Rx
- Label updated
- 2026-08-25
- TOKYO MEDI verified
- 2026-09-22
Source officielle
These links go directly to PMDA records for this Japanese product. Professional and patient-facing sources are separated.